Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice—II. Altered cell-mediated immunity and tumor resistance
- 1 January 1986
- journal article
- research article
- Published by Elsevier BV in International Journal of Immunopharmacology
- Vol. 8 (2), 189-198
- https://doi.org/10.1016/0192-0561(86)90058-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetateInternational Journal of Immunopharmacology, 1985
- Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistanceToxicology and Applied Pharmacology, 1984
- Studies of immune function and host resistance in B6C3F1 mice exposed to formaldehydeToxicology and Applied Pharmacology, 1984
- Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.The Journal of Immunology, 1983
- Natural host defence during oncogenesis. NK activity and dimethylbenzanthracene carcinogenesisInternational Journal of Cancer, 1983
- The relationship between competence for secretion of H2O2 and completion of tumor cytotoxicity by BCG-elicited murine macrophages.The Journal of Immunology, 1982
- The role of transmethylation reactions in regulating the binding of BCG-activated murine macrophages to neoplastic target cells.The Journal of Immunology, 1981
- In vitro augmentation of rat natural killer (NK) cell activity.The Journal of Immunology, 1981
- Assessment of Immunobiological Effects Induced by Chemicals, Drugs or Food Additives. II. Studies with CyclophosphamideDrug and Chemical Toxicology, 1979
- Reduced Antibody Titers in Mice Treated with Carcinogenic and Cancer Chemotherapeutic AgentsExperimental Biology and Medicine, 1952